137 related articles for article (PubMed ID: 948642)
1. [Results of associated immunosuppressive -- antiphlogistic treatment of proliferative glomerulonephritis (author's transl)].
Szewczyk Z; Szepietowski T; Falkiewicz K; Rabczyński J
Przegl Lek; 1976; 33(5):550-4. PubMed ID: 948642
[No Abstract] [Full Text] [Related]
2. [Comparison of two cyclophosphamide treatment regimens in nephrotic patients with chronic glomerulonephritis].
Krasnova TN; Shilov EM; Tareeva IE; Gordovskaia NB; Lavrova ON; Miroshnichenko NG; Troepol'skaia OV; Ivanova LV; Ivanov AA
Ter Arkh; 1998; 70(6):14-7. PubMed ID: 9695216
[TBL] [Abstract][Full Text] [Related]
3. [Effects of pathogenetic therapy on blood cholesterol in patients with glomerulonephritis].
Neverov NI; Stavrovskaia EV; Kolina IB; Shvetsov MIu; Zakharova EV; Shilov EM
Ter Arkh; 2001; 73(6):37-40. PubMed ID: 11521519
[TBL] [Abstract][Full Text] [Related]
4. [Effects of cyclophosphamide on the length of remission in patients suffering from glomerulonephritis with nephrotic syndrome].
Duman VL; Shkerina LI; Shilov EM
Klin Med (Mosk); 2005; 83(10):48-50. PubMed ID: 16320847
[TBL] [Abstract][Full Text] [Related]
5. [Immunosuppressors and immunostimulants in the treatment of chronic glomerulonephritis patients with the nephrotic syndrome].
Nazar PS
Vrach Delo; 1987 Mar; (3):86-9. PubMed ID: 3590711
[No Abstract] [Full Text] [Related]
6. [Immunologic problems of glomerulonephritis].
Dutz H; Philipp H
Z Arztl Fortbild (Jena); 1971 Jun; 65(11):554-60. PubMed ID: 5570284
[No Abstract] [Full Text] [Related]
7. [Sandimmun in the treatment of chronic glomerulonephritis with the nephrotic syndrome].
Krasnova TN; Tareeva IE; Shilov EM; Mukhin NA; Miroshnichenko NG
Ter Arkh; 1997; 69(6):21-3. PubMed ID: 9297266
[TBL] [Abstract][Full Text] [Related]
8. [Indications and limitations of immunosuppressive therapy in chronic glomerulonephritis].
Ponticelli C; Brancaccio D; Locatelli F; Imbasciati E
Minerva Nefrol; 1969; 16(3):228-34. PubMed ID: 5356052
[No Abstract] [Full Text] [Related]
9. [Results of 2-year use of the immunosuppressive drugs dipyridamole and methindol in the treatment of patients with chronic mesangiocapillary glomerulonephritis].
Kacprzyk F; Kubala L; Chrzanowski W; Pastuszko-Maryniarczyk T
Pol Tyg Lek; 1987 Aug; 42(34):1046-9. PubMed ID: 3422838
[No Abstract] [Full Text] [Related]
10. [Results of immunosuppressive therapy of chronic glomerulonephritis in 400 patients].
Müller V; Natusch R; Göbel U; Laske HR; Sperschneider H; Pap I; Sinn W; Koall W; Achenbach H; Tredt HJ
Z Urol Nephrol; 1985 Jan; 78(1):39-55. PubMed ID: 3976309
[TBL] [Abstract][Full Text] [Related]
11. [Immunosuppressive therapy of nephropathies (author's transl)].
Wegmüller E; Hodler J
Ther Umsch; 1979 May; 36(5):408-17. PubMed ID: 36683
[No Abstract] [Full Text] [Related]
12. [Immunopathological bases of the treatment of glomerulonephritis].
Vercellone A; Segoloni G; Stratta P; Coppo R; Triolo G; Messina M
Minerva Med; 1978 Aug; 69(38):2611-24. PubMed ID: 152419
[No Abstract] [Full Text] [Related]
13. [Therapeutic effect of cyclophosphamide in patients with chronic glomerulonephritis with nephrotic syndrome].
Duman VL
Ter Arkh; 2002; 74(6):39-41. PubMed ID: 12136481
[TBL] [Abstract][Full Text] [Related]
14. [Results of the treatment of mesangiocapillary glomerulonephritis].
Rodríguez JA; Olmos A; Ferrer E; Mauri JM; Capdevilla L; Codina S; Alsina J; Camps J; Piera L
Rev Clin Esp; 1975 Dec; 139(5):415-22. PubMed ID: 1215585
[No Abstract] [Full Text] [Related]
15. Minimal change lesion with nephrotic syndrome and focal glomerular sclerosis. (Variations of minimal proliferative intercapillary glomerulonephritis with the nephrotic syndrome).
Bohle A; Fischbach H; Wehner H; Woerz U; Edel HH; Kluthe R; Scheler F
Clin Nephrol; 1974; 2(2):52-8. PubMed ID: 4830512
[No Abstract] [Full Text] [Related]
16. [The treatment of nephrotic-type chronic glomerulonephritis with Sandimmun (cyclosporin A)].
Mukhin NA; Tareeva IE; Krasnova TN; Shilov EM; Miroshnichenko NG
Ter Arkh; 1995; 67(8):13-5. PubMed ID: 7482320
[TBL] [Abstract][Full Text] [Related]
17. [Comparative evaluation of the effectiveness of diverse variants of drug therapy in chronic glomerulonephritis].
Popova LA
Ter Arkh; 1979; 51(1):77-83. PubMed ID: 432837
[No Abstract] [Full Text] [Related]
18. [Renal changes in Schönlein-Henoch disease in the light of our own observations].
Rowecka-Trzebicka K; Wojnarowski M
Pediatr Pol; 1971 May; 46(5):595-600. PubMed ID: 5091770
[No Abstract] [Full Text] [Related]
19. Idiopathic extramembranous glomerulonephritis in children. Morphology and natural history.
Habib R; Kleinknecht C
Perspect Nephrol Hypertens; 1973; 1 Pt 1():449-59. PubMed ID: 4536437
[No Abstract] [Full Text] [Related]
20. [Treatment of oligo-anuric forms of acute glomerulonephritis].
Zosin C; Mănescu N
Med Interna (Bucur); 1973 Jun; 25(6):667-76. PubMed ID: 4793938
[No Abstract] [Full Text] [Related]
[Next] [New Search]
